65,437 trials
Rheumatoid Arthritis
Primary: Percentage of Participants Who Achieved American College of Rheumatology 20 Percent (%) Response Criteria (ACR20) Assessed Using High-Sensitivity C-reactive Protein…
Surgery
Primary: Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin — 78; 84; 54; 56 Percent of sites
Tobacco Use Disorder
Primary: Quit Rate — 13; 23 Participants
Alzheimer Disease · Mild Cognitive Impairment
Primary: Flortaucipir PET Imaging (Quantitative) — 1.31; 1.13; 1.15; 1.08 standardized uptake value ratio (SUVr) — p=<0.0001
Breast Neoplasms
Primary: Overview of the Number of Participants With at Least One Treatment-Emergent Adverse Event, Severity Determined According to National Cancer Institute Common Terminology…
Hypersensitivity
Primary: Irritation Response Evaluation According to Erythema Scoring Scale During Induction Phase - All Enrolled Subjects — 2182; 2 Test site
Psoriasis
Primary: Percentage of Participants With a Static Physician's Global Assessment of (sPGA) (0,1) With at Least a 2-point Improvement From Baseline — 6.5; 69.3 Percentage of…
Infections, Streptococcal · Streptococcus Pneumoniae
Primary: Person Year Rate as Regards Subjects With Culture-confirmed IPD Due to Any of the 10 Pneumococcal Vaccine Serotypes. In Children Starting Vaccination Within 7 Months of…
Pelvic Organ Prolapse
Primary: Number of Participants* With Serious Adverse Events — 4; 3 Participants
Anemia, Iron Deficiency · Inflammatory Bowel Diseases
Primary: The Percentage of Patients With Normalised Hb Levels at 12 Weeks After Initiation of Feraccru®. — 19; 11 Participants
Depressive Disorder, Major
Primary: Change From Baseline in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at 24 Hours Post First Dose (Last Observation Carried Forward [LOCF] Data)…
Tetrahydrobiopterin Deficiencies · Hyperphenylalaninemia, Non-Phenylketonuric
Primary: Blood Phenylalanine(Phe) Levels Measured at Specified Timepoints — 132.9; 72.2; 315.0; 104.1 μmol/L
Alzheimer Disease
Primary: Brain Flortaucipir Uptake — 1.780; 1.317; 1.128; 1.107 standardized uptake value ratio (SUVr)
Acute Pain
Primary: Number of Patients Who Respond to Study Medication at the 48-hr Numeric Pain Rating Scale (NRS) Assessment Compared to Placebo. — 38; 49; 52; 12 Participants
Advanced Cancer · Metastatic Cancer
Primary: Number of Participants With One or More Drug Related Adverse Events — 12; 13 Participants